Bioequivalence Study of Esomeprazole 20 Milligram (mg) Delayed-Release Capsules in Healthy Adult Participants

Condition:   Gastrointestinal Diseases Interventions:   Drug: Esomeprazole 20 mg Delayed-Release Capsules;   Drug: Esomeprazole 20 mg Delayed-Release Capsules (Nexium 24HR) Sponsor:   GlaxoSmithKline Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials